Evaluation of Bone Union Following Anterior Cervical Fusion Using a NovoMax™
1 other identifier
interventional
76
1 country
1
Brief Summary
The purpose of this study is to evaluate the efficacy and safety of NovoMax™ in Anterior Cervical Interbody Fusion - Comparison of NovoMax™ versus ChronOs®.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 21, 2015
CompletedFirst Posted
Study publicly available on registry
April 24, 2015
CompletedStudy Start
First participant enrolled
May 21, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2017
CompletedJanuary 4, 2019
January 1, 2019
1.7 years
April 21, 2015
January 3, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Bone Fusion With CT and Dynamic radiographs(X-ray)(Post operative 6 Months)
Evaluation of bone fusion between bone substitutes and cervical vertebral endplates with 3-dimensional CT and X-ray at 6 months after operation (ACDF).
at 6 months after surgery (ACDF)
Secondary Outcomes (1)
VAS of Neck Pain(Post operative 6 Months)
at 6 months after surgery (ACDF)
Study Arms (2)
Cervios ChronOs
EXPERIMENTALThe ACDF surgery will be carried out with Cervios ChronOs(TM), which is the PEEK cage filled with b-TCP.
NovoMax™
EXPERIMENTALThe ACDF surgery will be carried out with NovoMax™, which is the bioactive glass ceramic intervertebral spacer
Interventions
The ACDF surgery will be carried out with Cervios ChronOs after randomization procedure.
The ACDF surgery will be carried out with NovoMax™ after randomization procedure.
Eligibility Criteria
You may qualify if:
- The patient who is expected to receive anterior cervical discectomy and fusion operation.
- Volunteer for this study with written consent.
You may not qualify if:
- Patient with cervical spine fracture, infection and malignant tumor
- Below -3.5 T-score by DEXA bone densitometry
- Patient who is not suitable for this study judged by principal investigator
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- BioAlpha Inc.lead
Study Sites (1)
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, 463-707, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jin Sup Yeom, MD. Ph.D.
Seoul National University Bundang Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 21, 2015
First Posted
April 24, 2015
Study Start
May 21, 2015
Primary Completion
February 1, 2017
Study Completion
February 1, 2017
Last Updated
January 4, 2019
Record last verified: 2019-01